134 related articles for article (PubMed ID: 22685016)
1. Urinary sediment ICAM-1 level in lupus nephritis.
Guan J; Wang G; Tam LS; Kwan BC; Li EK; Chow KM; Li PK; Szeto CC
Lupus; 2012 Oct; 21(11):1190-5. PubMed ID: 22685016
[TBL] [Abstract][Full Text] [Related]
2. Urine sVCAM-1 and sICAM-1 levels are elevated in lupus nephritis.
Howe HS; Kong KO; Thong BY; Law WG; Chia FL; Lian TY; Lau TC; Chng HH; Leung BP
Int J Rheum Dis; 2012 Feb; 15(1):13-6. PubMed ID: 22324942
[TBL] [Abstract][Full Text] [Related]
3. Serum and urinary free microRNA level in patients with systemic lupus erythematosus.
Wang G; Tam LS; Li EK; Kwan BC; Chow KM; Luk CC; Li PK; Szeto CC
Lupus; 2011 Apr; 20(5):493-500. PubMed ID: 21372198
[TBL] [Abstract][Full Text] [Related]
4. Urinary FOXP3 mRNA in patients with lupus nephritis--relation with disease activity and treatment response.
Wang G; Lai FM; Tam LS; Li EK; Kwan BC; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2009 Jul; 48(7):755-60. PubMed ID: 19458162
[TBL] [Abstract][Full Text] [Related]
5. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis.
Lu J; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Wang G; Li PK; Szeto CC
Nephrology (Carlton); 2012 May; 17(4):346-51. PubMed ID: 22295894
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary levels of the leukocyte adhesion molecules ICAM-1 and VCAM-1 in human lupus nephritis with advanced renal histological changes: preliminary findings.
Abd-Elkareem MI; Al Tamimy HM; Khamis OA; Abdellatif SS; Hussein MR
Clin Exp Nephrol; 2010 Dec; 14(6):548-57. PubMed ID: 20714774
[TBL] [Abstract][Full Text] [Related]
7. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
8. Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis.
Wang G; Lai FM; Tam LS; Li KM; Lai KB; Chow KM; Li KT; Szeto CC
J Rheumatol; 2007 Dec; 34(12):2358-64. PubMed ID: 17985404
[TBL] [Abstract][Full Text] [Related]
9. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
[TBL] [Abstract][Full Text] [Related]
11. [Urinary soluble intercellular adhesion molecule-1 and vascular cellular adhesion molecule-1: potential biomarkers of active lupus nephritis].
Wu C; Yang M; Zhou Z; Feng X; Zhong X; Cui S; Wu L; Cao W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1272-6, 1282. PubMed ID: 26403737
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients.
Rosa RF; Takei K; Araújo NC; Loduca SM; Szajubok JC; Chahade WH
J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263
[TBL] [Abstract][Full Text] [Related]
13. The effect of immunosuppressive therapy on the messenger RNA expression of target genes in the urinary sediment of patients with active lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Nephrol Dial Transplant; 2006 Jun; 21(6):1534-40. PubMed ID: 16449281
[TBL] [Abstract][Full Text] [Related]
14. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
15. Expression of chemokine and fibrosing factor messenger RNA in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Wong TY; Szeto CY; Li PK; Szeto CC
Arthritis Rheum; 2004 Sep; 50(9):2882-90. PubMed ID: 15457456
[TBL] [Abstract][Full Text] [Related]
16. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Nephrology (Carlton); 2006 Jun; 11(3):219-25. PubMed ID: 16756635
[TBL] [Abstract][Full Text] [Related]
17. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
18. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
Tang Z; Zhang J; Zhang S; Li L
Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
[TBL] [Abstract][Full Text] [Related]
19. Soluble intercellular adhesion molecule-1 (ICAM-1) in serum and urine: correlation with renal expression of ICAM-1 in patients with kidney disease.
Lhotta K; Schlögl A; Kronenberg F; Joannidis M; König P
Clin Nephrol; 1997 Aug; 48(2):85-91. PubMed ID: 9285144
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis.
Chan RW; Tam LS; Li EK; Lai FM; Chow KM; Lai KB; Li PK; Szeto CC
Arthritis Rheum; 2003 May; 48(5):1326-31. PubMed ID: 12746905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
